Tag: ESR1

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence

Switching to camizestrant after ESR1 mutation detection prolongs progression free survival in advanced breast cancer

byZhenyu Liand1 others

August 28, 2025

1. In patients with ER-positive, HER2-negative advanced breast cancer who developed an ESR1 mutation during first-line aromatase inhibitor plus CDK4/6 ...

#VisualAbstract: Switch to fulvestrant and palbociclib may improve survival in patients with advanced breast cancer and ESR1 mutation

byTeddy Guo

January 31, 2023

Click to read this study in The Lancet Oncology.

JAK2 and TET2 mutations temporally linked with myeloproliferative disorder outcomes

Fulvestrant for treatment of estrogen receptor-positive, HER2-negative advanced breast cancer may improve progression free survival using ESR1 mutation as guidance

byKassandra McFarlaneand1 others

October 10, 2022

1. Median progression free survival was longer in the fulvestrant and palbociclib group compared to the aromatase inhibitor plus palbociclib ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result